Patents by Inventor Rodolfo Vicetti MIGUEL

Rodolfo Vicetti MIGUEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Increasing Epithelial Barrier Function
    Publication number: 20220362330
    Abstract: Provided herein, inter alia, are compositions for the modulation of epithelium function, the compositions comprising EphrinA3 protein or EphrinA2 protein, fusions thereof, fragments thereof, or oligonucleotides encoding the same. Also provided are methods for modulating epithelium function, the methods comprising administration of compositions provided herein, including embodiments thereof.
    Type: Application
    Filed: October 7, 2020
    Publication date: November 17, 2022
    Inventors: Thomas Cherpes, Rodolfo Vicetti Miguel, Nirk Quispe Calla
  • -activated B cell platforms and methods thereof
    Patent number: 11253582
    Abstract: Disclosed herein is a Chlamydia-activated B cell (CAB) platform. Also disclosed is a method of enhancing a population of B cells, comprising exposing said B cells to Chlamydia spp. under conditions suitable to enhance the population of B cells, such that expansion and differentiation of said B cells takes place, and said B cells are exposed or crosslinked to an antigen. Also disclosed are methods of producing said CABs, and treating a subject in need thereof with said CABs.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: February 22, 2022
    Assignee: Ohio State Innovation Foundation
    Inventors: Thomas Cherpes, Rodolfo Vicetti Miguel
  • CHLAMYDIA-ACTIVATED B CELL PLATFORMS AND METHODS THEREOF
    Publication number: 20200289635
    Abstract: Disclosed herein is a Chlamydia-activated B cell (CAB) platform. Also disclosed is a method of enhancing a population of B cells, comprising exposing said B cells to Chlamydia spp. under conditions suitable to enhance the population of B cells, such that expansion and differentiation of said B cells takes place, and said B cells are exposed or crosslinked to an antigen. Also disclosed are methods of producing said CABs, and treating a subject in need thereof with said CABs.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 17, 2020
    Inventors: Thomas Cherpes, Rodolfo Vicetti Miguel
  • -activated B cell platforms and methods thereof
    Patent number: 10688171
    Abstract: Disclosed herein is a Chlamydia-activated B cell (CAB) platform. Also disclosed is a method of enhancing a population of B cells, comprising exposing said B cells to Chlamydia spp. under conditions suitable to enhance the population of B cells, such that expansion and differentiation of said B cells takes place, and said B cells are exposed or crosslinked to an antigen. Also disclosed are methods of producing said CABs, and treating a subject in need thereof with said CABs.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: June 23, 2020
    Assignee: Ohio State Innovation Foundation
    Inventors: Thomas Cherpes, Rodolfo Vicetti Miguel
  • CHLAMYDIA-ACTIVATED B CELL PLATFORMS AND METHODS THEREOF
    Publication number: 20180028642
    Abstract: Disclosed herein is a Chlamydia-activated B cell (CAB) platform. Also disclosed is a method of enhancing a population of B cells, comprising exposing said B cells to Chlamydia spp. under conditions suitable to enhance the population of B cells, such that expansion and differentiation of said B cells takes place, and said B cells are exposed or crosslinked to an antigen. Also disclosed are methods of producing said CABs, and treating a subject in need thereof with said CABs.
    Type: Application
    Filed: February 10, 2016
    Publication date: February 1, 2018
    Inventors: Thomas CHERPES, Rodolfo Vicetti MIGUEL